News

Cancer Research7d
Abstract SY27-02: Exploring the significance of somatic mtDNA mutations in the context of acute leukemia
St. Jude Children's Research Hospital, Memphis, TN.
Cancer Research7d
Abstract CT185: Trispecific EGFR x cMET x VEGF antibody, TAVO412, has clinical responses in esophageal and lung cancers
Search for other works by this author on: ...
Cancer Research11d
Abstract 410: The BTK degrader BGB-16673 shows anti-tumor activity in marginal zone lymphoma models
IOR - Institute of Oncology Research, Bellinzona, Switzerland.
Cancer Research5d
A Guide to Extrachromosomal DNA: Cancer’s Dynamic Circular Genome
1Department of Pathology, Stanford University School of Medicine, Stanford, California.
Cancer Research5d
Pembrolizumab Boosts EFS in Head and Neck Cancer
According to data announced today at the American Association for Cancer Research Annual Meeting 2025, Merck’s anti-PD-1 mAb pembrolizumab (Keytruda) led to significant improvements in event-free ...
Cancer Research11d
Abstract 1591: Mechanisms of BPM31510-induced cell death in cancer: lipid peroxidation and apoptosis pathways
Search for other works by this author on: ...
Cancer Research9d
Prevalence and Review of Major Modifiable Cancer Risk Factors, HPV Vaccination, and Cancer Screenings in the United States: 2025 Update
Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia. *Corresponding Author: Priti Bandi, Risk Factors and Screening Research, Surveillance and Health Equity Science, ...
Cancer Research11d
Abstract 1530: Elucidating the role of exogenous lipids in ferroptosis in castration resistant prostate cancer
Search for other works by this author on: ...
Cancer Research11d
Depletion of effector regulatory T cells associates with major response to induction dual immune checkpoint blockade
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
Cancer Research4d
“A Game-Changer” HER2 TKI for NSCLC
The investigational HER2-selective tyrosine kinase inhibitor zongertinib appears remarkably effective in patients with HER2-mutant non–small cell lung cancer. Robust, durable responses were seen in ...
Cancer Research11d
Abstract 4329: Developing oncogenic mutant-selective antisense oligonucleotide to treat PIK3CA-mutated cancers
Search for other works by this author on: ...
Cancer Research11d
Abstract 3057: Telomerase and G-quadruplex dual-targeting chimera inhibits melanoma via telomere disruption
Search for other works by this author on: ...